Am J Transplant, Volume 19, Suppl 3 Archives - Page 107 of 214 - ATC Abstracts

2019 American Transplant Congress
Immunization Status at the Time of Pediatric Liver Transplant: A 1-year Study through The Society of Pediatric Liver Transplantation
A. G. Feldman¹, A. Kempe², B. L. Beaty³, R. Torres¹, D. Curtis⁴, S. S. Sundaram¹
¹Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado, Aurora, CO, ²Pediatrics, University of Colorado, Aurora, CO, ³University of Colorado, Aurora, CO, ⁴Pediatric Infectious Diseases, University of Colorado, Aurora, CO
*Purpose: Vaccine preventable infections are a serious and common complication following transplant. Immunizations are a minimally invasive and cost-effective approach to reducing infections. The objectives…
2019 American Transplant Congress
Heart En Bloc Thymus Cotransplantation in NHPs
J. O¹, W. Sommer², K. Pruner³, J. T. Paster⁴, I. M. Hanekamp¹, A. Dehnadi¹, I. Rosales¹, R. N. Smith¹, R. B. Colvin¹, G. Benichou¹, J. S. Allan¹, J. C. Madsen¹
¹Center for Transplantation Sciences, MGH, Boston, MA, ²Hannover Medical School, Hannover, Germany, ³University of Washington, Seattle, WA, ⁴MGH, Boston, MA
*Purpose: Tolerance of isolated cardiac allografts has never been achieved in NHPs. We investigated whether a cotransplanted, vascularized, donor thymus could induce tolerance of a…
2019 American Transplant Congress
Deficiency of the Transcription Factor Satb1 in T Cells Promotes Solid Organ Allograft Survival
P. K. Gupta¹, M. L. Miller², L. Chen¹, Y. Wang¹, J. Conejo-Garcia³, A. Chong¹, M. Alegre¹
¹University of Chicago, Chicago, IL, ²University of Pittsburgh, Pittsburgh, PA, ³Moffitt Cancer Center & Research Institute, Tampa, FL
*Purpose: Conventional CD4+ T cells are key effectors of allograft rejection and novel therapies limiting their response may hold promise in the context of organ…
2019 American Transplant Congress
Xenorejection of Porcine Islets in Humanized Mice is Dominated by a Human Th17 Cytokine Immune Response
F. T. Lee¹, A. Dangi², M. Burnette², B. Hering³, X. Luo²
¹Transplant Surgery, Northwestern University, Chicago, IL, ²Nephrology, Duke University, Durham, NC, ³Diabetes Institute, University of Minnesota, Minneapolis, MN
*Purpose: We have previously shown that interleukin(IL)-17 producing CD4 T cells (Th17 response) dominate in the early anti-donor immune responses of a pig-to-mouse xenogeneic model…
2019 American Transplant Congress
Population-Based Modeling of Prototypes and Determinants of Allograft Function Trajectories after Kidney Transplantation: Impact for Patient Monitoring and Risk Stratification
M. Raynaud¹, O. Aubert¹, M. Naesens², I. Juric³, N. Basic³, N. Kamar⁴, E. Huang⁵, S. Jordan⁵, B. Orandi⁶, D. Segev⁶, M. Stegall⁷, E. Morelon⁸, M. Giral⁹, E. Bailly¹⁰, E. Akalin¹¹, G. Gupta¹², M. Ladrière¹³, M. Buchler¹⁰, P. Reese¹⁴, C. Lefaucheur¹, A. Loupy¹
¹Paris, ., France, ²Leuven, ., Belgium, ³Zagreb, ., Croatia, ⁴Toulouse, ., France, ⁵Los Angeles, ., CA, ⁶Baltimore, ., MD, ⁷Rochester, ., MN, ⁸Lyon, ., France, ⁹Nantes, ., France, ¹⁰Tours, ., France, ¹¹New York, ., NY, ¹²Richmond, ., VA, ¹³Nancy, ., France, ¹⁴Philadelphia, ., PA
*Purpose: Although the current gold standard of kidney allograft patients monitoring relies on GFR assessment, little is known about long-term GFR trajectories prototypes and their…
2019 American Transplant Congress
Outcomes in Non-A1 and Non A1 B to B Deceased Donor Renal Transplantation Are Comparable to B Donor Renal Transplants
A. Brar, L. Kwon, A. Gruessner, F. Tedla, R. Gruessner, N. Sumrani, D. John, J. Renz, M. O. Salifu
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Blood type B patients wait longer to get deceased donor (DD) renal transplants compared to other blood types. On December 2014, the US national…
2019 American Transplant Congress
Robotic-Assisted versus Open- Kidney Transplantation in Non-Obese Recipients
P. R. Modi, B. Pal, S. Singla, R. Chauhan, V. Kothari, A. Mishra, M. Modi, B. Butala, V. Kute, H. Patel, V. Trivedi
Transplantation Surgery and Urology, Institute of Kidney Diseases and Research Centre, Ahmedabad, India
*Purpose: Robotic Kidney Transplantation (RKT) is emerging modality of treatment for patient with end stage kidney diseases. It is accepted for obese recipients. However, there…
2019 American Transplant Congress
An 8-Gene Expression Assay in Peripheral Blood for Diagnosis of Antibody-Mediated Rejection after Kidney Transplantation
E. Van Loon¹, S. Gazut², S. Yazdani¹, E. Lerut¹, H. de Loor¹, M. Coemans¹, L. Noël³, L. Thorrez¹, L. Van Lommel¹, F. Schuit¹, D. Lambrechts¹, T. Van Brussel¹, B. Sprangers¹, D. Kuypers¹, M. Essig⁴, W. Gwinner⁵, D. Anglicheau⁶, P. Marquet⁷, M. Naesens¹
¹Catholic University Leuven, Leuven, Belgium, ²CEA, Gif-sur-Yvette, France, ³Necker-Enfants Malades Institute, Paris, France, ⁴CHU Limoges, Limoges, France, ⁵Hannover Medical School, Hannover, Germany, ⁶Paris Descartes, Sorbonne Paris Cité University, Paris, France, ⁷RTRS Centaure, Necker Hospital, Paris, France
*Purpose: Antibody-mediated rejection is a leading cause of graft failure after kidney transplantation. The diagnosis of antibody-mediated rejection is made by combining assessment of circulating…
2019 American Transplant Congress
Novel Activation Responses by Endothelial Cells within the Pro-Tolerogenic Intragraft Microenvironment
J. Wedel¹, K. Liu¹, P. T. Sage², C. V. Carman³, P. Bobrowicz⁴, S. Kong⁵, B. McLaughlin⁴, D. M. Briscoe¹
¹Transplant Research Program, Boston Children's Hospital, Boston, MA, ²Transplant Research Center, Brigham and Woman Hospital, Boston, MA, ³Harvard T.H. Chan School of Public Health, Boston, MA, ⁴Compass Therapeutics, Cambridge, MA, ⁵Computational Health Informatics Program, Boston Children's Hospital, Boston, MA
*Purpose: Current paradigms indicate that endothelial cells (EC) within allografts participate in the initiation and progression of allograft rejection. However, little is known about their…
2019 American Transplant Congress
Results of Litmus (nct 02541916): The Liver Immune Tolerance Bio Marker Utilization Study
A. Chruscinski¹, V. Rojas-Luengas¹, S. Moshkelgosha¹, J. Luo², H. Yowanto², Z. Galvin¹, L. Lilly¹, R. Smith¹, E. Renner¹, J. Zhang¹, D. Grant¹, O. Adeyi¹, H. Atkins³, P. Juni⁴, N. Selzner¹, S. Juvet¹, G. Levy¹
¹Multi-Organ Transplantation, University Health Network, Toronto, ON, Canada, ²Sciex, Brea, CA, ³Ottawa Hospital Research Institute, Ottawa, ON, Canada, ⁴University of Toronto, Toronto, ON, Canada
*Purpose: Previously we reported a novel biomarker gene set for the identification of tolerance in murine models of rapamycin-induced cardiac tolerance and spontaneous hepatic tolerance.…